Literature DB >> 27053887

Comparative study of changing patterns of concanavalin A-binding proteins in early stage of cholesterol gallstone formation.

Y Q Chen1, D Cai1, Y L Zhang1, T F Hua1.   

Abstract

AIM: To elucidate the importance and the changing patterns of biliary concanavalin A-binding proteins (CPs) in the early stage of cholesterol gallstone formation.
METHODS: CP concentration and nucleation activity were measured by lectin affinity chromatography in bile samples of patients with cholesterol gallstones, pigment gallstones, gallbladder cholesterosis and non-biliary diseases.
RESULTS: The concentrations of CPs were much higher in patients with cholesterol gallstones (0.39 ± 0.11 g/L, n = 36, P < 0.01) or gallbladder cholesterosis (0.40 ± 0.09 g/L, n = 9, P < 0.01) than in those with pigment gallstones (0.2 ± 0.12 g/L, n = 7) and/or non-biliary diseases (0.27 ± 0.09 g/L, n = 10). Pronucleating activities were much stronger in patients with cholesterol gallstones (nucleation time ratio: 0.57 ± 0.21, n = 5, P < 0.01 vs pigment gallstones and/or non biliary diseases) and gallbladder cholesterosis (nucleation time ratio: 0.44 ± 0.23, n = 5, P < 0.01 vs pigment gallstones or non-biliary diseases). The binding percentages of CPs to model biliary vesicles were also higher for patients with cholesterol gallstones (n = 6) than those with pigment gallstones (n = 6) (2.4% ± 0.9% vs 0.9% ± 0.5%, P < 0.01).
CONCLUSION: Hypersecretion of CPs, especially those in vesicular phase, may be an important change in the early stage of cholesterol gallstone formation.

Entities:  

Keywords:  Bile; Cholesterol gallstone; Chromatography; Concanavalin A binding proteins

Year:  1997        PMID: 27053887      PMCID: PMC4806255          DOI: 10.3748/wjg.v3.i4.257

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  Separation of bile vesicles and micelles by gel filtration chromatography: the importance of the intermicellar bile salt concentration.

Authors:  B G Stone; L J Larsen; D A Knoll; V A Bloomfield; W C Duane
Journal:  J Lab Clin Med       Date:  1992-05

Review 2.  Biochemistry of gallstone formation.

Authors:  I A Bouchier
Journal:  Clin Gastroenterol       Date:  1983-01

Review 3.  Biliary cholesterol transport and precipitation: introduction and overview of conference.

Authors:  S M Strasberg; P R Harvey
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

4.  Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile.

Authors:  A Kibe; R T Holzbach; N F LaRusso; S J Mao
Journal:  Science       Date:  1984-08-03       Impact factor: 47.728

5.  Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile.

Authors:  N H Afdhal; N Niu; D Gantz; D M Small; B F Smith
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

6.  Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones.

Authors:  P R Harvey; G A Upadhya; S M Strasberg
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

7.  Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease.

Authors:  A K Groen; C Noordam; J A Drapers; P Egbers; P L Jansen; G N Tytgat
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

8.  Rapid isolation of vesicular and micellar carriers of biliary lipids by ultracentrifugation.

Authors:  L Amigo; C Covarrubias; F Nervi
Journal:  J Lipid Res       Date:  1990-02       Impact factor: 5.922

9.  Isolation and purification of human biliary vesicles with potent cholesterol-nucleation-promoting activity.

Authors:  J F Miquel; A Rigotti; E Rojas; E Brandan; F Nervi
Journal:  Clin Sci (Lond)       Date:  1992-02       Impact factor: 6.124

10.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.